A recent investigation demonstrated that the HIF-1α level is markedly enhanced in ovarian cancer in comparison with that in normal ovarian tissues and that the enhanced expression of HIF-1α is related to markedly shorter overall patient survival. This evidence concerns the gene HIF1A and ovarian cancer.